{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:03:37Z","timestamp":1777910617265,"version":"3.51.4"},"reference-count":111,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T00:00:00Z","timestamp":1136419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Skin disease in patients with lupus erythematosus may be subdivided into two broad categories \u2013 those lesions that when biopsied demonstrate interface dermatitis and those that do not demonstrate interface dermatitis. The skin lesions that are represented by the interface dermatitis include discoid lupus erythematosus, subacute cutaneous lupus erythematosus and acute cutaneous lupus erythematosus. Patients with these \u2018specific\u2019 manifestations have varying degrees of systemic involvement from rare systemic disease in patients with localized discoid lupus erythematosus to common and often severe involvement in patients with acute cutaneous lupus erythematosus. Patients who do not demonstrate interface dermatitis also may have systemic disease and in some instances the skin manifestations are linked to some of the more severe systemic manifestations. Many patients with cutaneous lesions characterized by the interface dermatitis can be controlled with \u2018standard\u2019 therapies including sunscreens, protective clothing and behavioural alteration, and topical corticosteroids with or without an oral antimalarial agent. This review presents a brief summary of each common cutaneous manifestation of lupus erythematosus, its relationship to systemic involvement and treatment issues to effectively deal with the lupus erythematosus patient who has skin disease.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2006.00217.x","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T16:30:45Z","timestamp":1136478645000},"page":"13-27","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Cutaneous lupus erythematosus: A personal approach to management"],"prefix":"10.1111","volume":"47","author":[{"given":"Jeffrey P","family":"Callen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,5]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2005.05.003"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(81)80261-7"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1982.01650180046015"},{"key":"e_1_2_11_5_2","first-page":"256","article-title":"Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and\/or hypertrophic skin lesions","volume":"15","author":"Spann CR","year":"1988","journal-title":"J. Rheumatol."},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1967.01610030051008"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(97)80024-7"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1995.tb00966.x"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.8.1033"},{"key":"e_1_2_11_10_2","first-page":"68","article-title":"Lupus panniculitis: clinical perspectives from a case series","volume":"26","author":"Martens PB","year":"1999","journal-title":"J. Rheumatol."},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01510.x"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)02784-1"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2005.00331.x"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(85)80036-0"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1979.04010120007006"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310811"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.1.45"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.137.9.1196"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2005.00199.x"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550410018361"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02013.x"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2004.00094.x"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70020-I"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2000.00426.x"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu2037sa"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246251"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21041"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200105000-00004"},{"key":"e_1_2_11_29_2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archderm.1991.01680060080008","article-title":"Twenty percent of biopsy specimens from sun\u2010exposed skin of normal young adults demonstrate positive immunofluorescence","volume":"127","author":"Fabre VC","year":"1991","journal-title":"Arch. Dermatol."},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06196.x"},{"key":"e_1_2_11_31_2","first-page":"257","article-title":"Evidence\u2010based evaluation of immunomodulatory therapy of cutaneous manifestations of lupus","volume":"20","author":"Heath M","year":"2004","journal-title":"Adv. Dermatol."},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659509010639"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-1-49"},{"key":"e_1_2_11_34_2","first-page":"100","article-title":"Subacute cutaneous lupus erythematosus\u2010like eruption caused by hydrochlorothiazide","volume":"6","author":"Parodi A","year":"1989","journal-title":"Photodermatology"},{"key":"e_1_2_11_35_2","first-page":"709","article-title":"Thiazide diuretic\u2010induced subacute cutaneous lupus erythematosus","volume":"42","author":"Wollenberg A","year":"1991","journal-title":"Hautarzt"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70005-5"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02194.x"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.2576r.x"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.2576q.x"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-004-0731-6"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05235.x"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114565"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.11.1317"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-8-199910190-00031"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11033"},{"key":"e_1_2_11_46_2","first-page":"S372","article-title":"Two cases of etanercept\u2010induced lupus\u2010like syndrome in ra patients","volume":"44","author":"De Bandt M","year":"2001","journal-title":"Arthritis Rheum."},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200305000-00005"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90281-1"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511233332117"},{"key":"e_1_2_11_50_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/120347540300700310","article-title":"Subacute cutaneous lupus erythematosus induced by nifedipine","volume":"7","author":"Gubinelli E","year":"2003","journal-title":"J. Cutan. Med. Surg."},{"key":"e_1_2_11_51_2","first-page":"213","article-title":"Nitrndipine\u2010induced subacute cutaneous lupus erythematosus","volume":"13","author":"Marzano A","year":"2003","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_11_52_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2340\/0001555565447448","article-title":"Lupus erythematosus\u2010like eruption from captopril","volume":"65","author":"Patri P","year":"1985","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90392-5"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)80031-3"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80493-0"},{"key":"e_1_2_11_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320318"},{"key":"e_1_2_11_57_2","first-page":"1523","article-title":"Induktion eines subakuten kutanen lupus erythematodes durch psorale uv\u2010a\u2010therapie","volume":"62","author":"Neumann C.","year":"1987","journal-title":"Z. Hautkr."},{"key":"e_1_2_11_58_2","first-page":"392","article-title":"Cinnarizin \u2013 ein bisher unbekannter induktor eines lupus\u2010erythematodes\u2010ahnlichen syndroms","volume":"29","author":"Brenner W","year":"1978","journal-title":"Hautarzt"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678920244"},{"key":"e_1_2_11_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79887-1"},{"key":"e_1_2_11_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01527.x"},{"key":"e_1_2_11_62_2","doi-asserted-by":"crossref","unstructured":"GoebV BerthelotJ JolyP MejjadO De QuatrebarbesJ Reynaud\u2010HautinC VittecoqO Le LoetX.Leflunomide\u2010induced subacute cutaneous lupus erythematosus.Rheumatology2005;44:823\u20134.","DOI":"10.1093\/rheumatology\/keh586"},{"key":"e_1_2_11_63_2","first-page":"818","article-title":"Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases","volume":"31","author":"Chen M","year":"2004","journal-title":"J. Rheumatol."},{"key":"e_1_2_11_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01107.x"},{"key":"e_1_2_11_65_2","first-page":"471","article-title":"Drug\u2010induced lupus associated with col\u20103: report of 3 cases","volume":"137","author":"Ghate J","year":"2001","journal-title":"Arch. Dermatol."},{"key":"e_1_2_11_66_2","first-page":"505","article-title":"Lupus eritematoso cutaneo subagudo inducido por la crisoterapia en una arthritis reumatoide","volume":"182","author":"Balsa A","year":"1988","journal-title":"Rev Clin Esp"},{"key":"e_1_2_11_67_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1992.03490010053019","article-title":"Possible naproxen\u2010induced relapse of subacute cutaneous lupus erythematosus","volume":"268","author":"Parodi A","year":"1992","journal-title":"JAMA"},{"key":"e_1_2_11_68_2","first-page":"1237","article-title":"Dermatitis caused by aldactone of a lupic annular erythema type","volume":"114","author":"Leroy D","year":"1987","journal-title":"Ann. Dermatol. Venereol"},{"key":"e_1_2_11_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02013.x"},{"key":"e_1_2_11_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1999.tb01809.x"},{"key":"e_1_2_11_71_2","first-page":"231","article-title":"Report of an association between discoid lupus erythematosus and smoking","volume":"63","author":"Gallego H","year":"1999","journal-title":"Cutis"},{"key":"e_1_2_11_72_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2000.160604.x"},{"key":"e_1_2_11_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20426"},{"key":"e_1_2_11_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh325"},{"key":"e_1_2_11_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.01.044"},{"key":"e_1_2_11_76_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066428"},{"key":"e_1_2_11_77_2","first-page":"630","article-title":"Intralesional triamcinolone is effective for discoid lupus erythematosus of the palms and soles","volume":"12","author":"Callen JP.","year":"1985","journal-title":"J. Rheumatol."},{"key":"e_1_2_11_78_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-004-1024-2"},{"key":"e_1_2_11_79_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310019904"},{"key":"e_1_2_11_80_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018467"},{"key":"e_1_2_11_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.10169"},{"key":"e_1_2_11_82_2","first-page":"1716","article-title":"Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus","volume":"25","author":"Rahman P","year":"1998","journal-title":"J. Rheumatol."},{"key":"e_1_2_11_83_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103635"},{"key":"e_1_2_11_84_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246899"},{"key":"e_1_2_11_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1998.236"},{"key":"e_1_2_11_86_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-2-165"},{"key":"e_1_2_11_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1980.tb00162.x"},{"key":"e_1_2_11_88_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018345"},{"key":"e_1_2_11_89_2","first-page":"151","article-title":"Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases","volume":"124","author":"Delaporte E","year":"1997","journal-title":"Ann. Dermatol. Venereol."},{"key":"e_1_2_11_90_2","first-page":"21","article-title":"Sulfasalazine in the treatment of cutaneous lupus erythematosus: open trial in six cases","volume":"7","author":"Lagrange S","year":"1998","journal-title":"Lupus"},{"key":"e_1_2_11_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21358"},{"key":"e_1_2_11_92_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639109089051"},{"key":"e_1_2_11_93_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-0781.2003.00055.x"},{"key":"e_1_2_11_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06117.x"},{"key":"e_1_2_11_95_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.1.50"},{"key":"e_1_2_11_96_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19502.x"},{"key":"e_1_2_11_97_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304060-00002"},{"key":"e_1_2_11_98_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.131.5.620b"},{"key":"e_1_2_11_99_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archderm.1986.01660140060018","article-title":"Mechanism\u2010oriented assessment of isotretinoin in chronic of subacute cutaneous lupus erythematosus","volume":"122","author":"Newton RC","year":"1986","journal-title":"Arch. Dermatol."},{"key":"e_1_2_11_100_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.04510010083008"},{"key":"e_1_2_11_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050058"},{"key":"e_1_2_11_102_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06552.x"},{"key":"e_1_2_11_103_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04875.x"},{"key":"e_1_2_11_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380926"},{"key":"e_1_2_11_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1971.tb14112.x"},{"key":"e_1_2_11_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08471.x"},{"key":"e_1_2_11_107_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310018789"},{"key":"e_1_2_11_108_2","doi-asserted-by":"crossref","unstructured":"KreuterA HyunJ AltmeyerP GambichlerT.Intravenous immunoglobulin for recalcitrant subacute cutaneous lupus erythematosus.Acta Derm. Venereol.2005; doi: 10.1080\/00015550510037071","DOI":"10.1080\/00015550510037071"},{"key":"e_1_2_11_109_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.9.1124"},{"key":"e_1_2_11_110_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10271"},{"key":"e_1_2_11_111_2","first-page":"253","article-title":"Therapy of cutaneous lupus erythematosus with recombinant interferon alpha\u20102a","volume":"2","author":"Tebbe B","year":"1992","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_11_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80119-8"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2006.00217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2006.00217.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:44:07Z","timestamp":1697442247000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2006.00217.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,5]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1111\/j.1440-0960.2006.00217.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2006.00217.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,5]]},"assertion":[{"value":"2006-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}